Form 10-Q BOXSCORE BRANDS, INC. For: Mar 31

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2021

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

  

Commission File Number: 333-165972

 

BOXSCORE BRANDS, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware		22-3956444
(State or Other Jurisdiction of Incorporation or Organization)		(IRS Employer Identification No.)

 

3275 S. Jones Blvd, Suite 104, Las Vegas, NV		89146
(Address of principal executive offices)		(Zip Code)

 

800-998-7962

(Registrant’s telephone number, including area code)

 

1759 Clear River Falls Lane, Henderson, NV 89012

(Former Name, Former Address and Former Fiscal Year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐    No ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒ 

 

The number of shares outstanding of the registrant’s common stock, $0.001 par value per share, was 226,604,039 as of September 27, 2021.

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None

 

 

 

BOXSCORE BRANDS, INC.

FORM 10-Q

For the Three months Ended March 31, 2021

 

INDEX

 

	PAGE
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements	1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3. Quantitative and Qualitative Disclosure About Market Risk	17
Item 4. Controls and Procedures	17
PART II – OTHER INFORMATION
Item 2. Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities	18
Item 3. Defaults Upon Senior Securities	18
Item 4. Mine Safety Disclosures	18
Item 5. Other Information	18
Item 6. Exhibits	18
SIGNATURES	19
EXHIBIT INDEX

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

BOXSCORE BRANDS, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

		March 31,				December 31,
		2021				2020
Assets
Current assets
Cash		$	20,934			$	23,586
Prepaid expenses and other assets			2,632				9,789
Total current assets			23,566				33,375
Noncurrent assets
Property and equipment (net)			17,500				61,600
Total assets		$	41,066			$	94,975
Liabilities and Stockholders’ Deficit
Current Liabilities:
Accounts payable		$	318,337			$	314,533
Accrued expenses			338,512				390,398
Accrued interest			1,822,692				1,720,766
Senior convertible notes			288,804				402,704
Promissory notes payable			509,331				406,081
Convertible notes payable			4,897,899				4,769,400
Current capital lease obligation			45,699				146,734
Total current liabilities			8,221,274				8,150,616
Noncurrent liabilities:
Promissory notes payable			-				118,250
Convertible notes payable			524,950				481,350
Capital lease obligation			14,742				34,890
Derivative liabilities			1,231,122				3,083,255
Total noncurrent liabilities			1,770,814				3,717,745
Total Liabilities			9,992,088				11,868,361
Stockholders’ deficit
Common stock, $.001 par value, 600,000,000 shares authorized, 130,226,748 and 75,828,064 shares issued and outstanding, respectively			130,226				75,828
Additional paid in capital			6,435,132				6,281,241
Accumulated deficit			(16,516,380	)			(18,130,455	)
Total stockholders’ deficit			(9,951,022	)			(11,773,386	)
Total liabilities and stockholders’ deficit		$	41,066			$	94,975

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

 

BOXSCORE BRANDS, INC.

 

Condensed Consolidated Statements of Operations

(Unaudited)

 

		Three Months Ended				Three Months Ended
		March 31,				March 31,
		2021				2020
Revenue		$	-			$	-
Operating Expenses
General and administrative			73,495				51,582
Total operating expenses			73,495				51,582
Operating loss			(73,495	)			(51,582	)
Other Expenses (Income)
(Gain) loss on change in fair value of derivative liabilities			(1,852,133	)			394
Gain on settlement of liabilities			(31,326	)			-
Loss on sale of assets			-				12,074
Amortization and accretion of debt discount and deferred financing costs			-				2,657
Interest expense			195,889				151,489
Total other expenses (income)			(1,687,570	)			166,614
Income (loss) from operations before income taxes			1,614,075				(218,196	)
Provision for income taxes			-				-
Net income (loss)		$	1,614,075			$	(218,196	)
Net income (loss) per share – basic		$	0.02			$	(0.01	)
Net income (loss) per share – diluted		$	(0.00	)		$	(0.01	)
Weighted average common shares – basic			100,299,993				37,717,755
Weighted average common shares – diluted			267,515,038				37,717,755

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.  

 

 

BOXSCORE BRANDS, INC.

Consolidated Statements of Changes in Stockholders’ Deficit

(Unaudited)

 

		Common stock								Additional Paid in				Accumulated				Total Stockholders'
		Shares				Amount				Capital				Deficit				Deficit
Balance as of December 31, 2019			37,717,755			$	37,716			$	6,195,573			$	(14,198,142	)		$	(7,964,853	)
Net loss			-				-				-				(218,196	)			(218,196	)
Balance as of March 31, 2020			37,717,755			$	37,716			$	6,195,573			$	(14,416,338	)		$	(8,183,049	)
Balance as of December 31, 2020			75,828,064			$	75,828			$	6,281,241			$	(18,130,455	)		$	(11,773,386	)
Shares issued for note conversion			54,398,684				54,398				152,317				-				206,715
Fair value of warrants			-				-				1,574				-				1,574
Net income			-				-				-				1,614,075				1,614,075
Balance as of March 31, 2021			130,226,748			$	130,226			$	6,435,132			$	(16,516,380	)		$	(9,951,022	)

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

 

BOXSCORE BRANDS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

		Three Months Ended				Three Months Ended
		March 31,				March 31,
		2021				2020
Cash Flows from Operating Activities
Net income (loss)		$	1,614,075			$	(218,196	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock based compensation			1,574				-
Amortization and accretion of debt discount and deferred financing costs			-				2,657
Gain on settlement of liabilities			(31,326	)			-
(Gain) loss on change in fair value of debt and warrant liabilities			(1,852,133	)			394
Loss on sale of assets			-				12,074
Changes in operating assets and liabilities:
Accounts receivable			-				1,530
Prepaid expenses and other assets			2,000				-
Accounts payable and accrued expenses			15,417				107,095
Accrued interest			194,741				146,389
Amount due to officers			-				(67,022	)
Net cash used in operating activities			(55,652	)			(15,079	)
Cash Flows from Investing Activities:
Proceeds from sale of property and equipment			-				18,000
Net cash provided by investing activities			-				18,000
Cash Flows from Financing Activities
Proceeds from convertible notes			125,000				7,500
Repayments of capital lease obligations			(57,000	)			(10,421	)
Repayments of promissory notes			(15,000	)			-
Net cash provided by (used in) financing activities			53,000				(2,921	)
Net decrease in cash			(2,652	)			-
Cash, beginning of period			23,586				-
Cash, end of period		$	20,934			$	-
Supplemental disclosures:
Interest paid		$	-			$	-
Supplemental disclosures of non-cash items:
Accounts payable and accrued expenses exchanged for convertible note		$	47,100			$	54,227
Fixed assets under lease exchanged in settlement of lease liability		$	44,100			$	-
Senior convertible notes converted to common stock		$	113,900			$	-
Accrued interest on senior convertible notes converted to common stock		$	92,815			$	-

 

The accompanying notes are an integral part of the condensed consolidated unaudited financial statements.

 

 

BOXSCORE BRANDS, INC.

Notes to Condensed Consolidated Financial Statements

For the Three months Ended March 31, 2021 and 2020

(Unaudited)

 

Note 1 – Nature of the Business

 

BoxScore Brands, Inc. (formerly U-Vend Inc.) (the “Company”) formerly developed, marketed and distributed various self-serve electronic kiosks and mall/airport co-branded islands throughout North America. Due to the nationwide shutdown related to the COVID-19 pandemic, the Company spent a portion of 2020 restructuring and retiring certain corporate debt and obligations. The Company focused on implementing a new operational direction.  After a thorough evaluation process, the Company found that there is a substantial long-term demand for specific commodities relating to battery and new energy technologies. This presents a timely and unique opportunity based on rising demand characteristics.  By capitalizing on market trends and current sustainable energy government mandates and environmental, social, and corporate governance (ESG) initiatives, we will focus on bringing a vertically-integrated solution to market.

 

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring accruals considered necessary for a fair and non-misleading presentation of the financial statements have been included. Operating results for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. These interim consolidated financial statements should be read in conjunction with the December 31, 2020 audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on September 27, 2021.

 

The accompanying consolidated financial statements include the accounts of BoxScore Brands, Inc. and the operations of its wholly owned subsidiaries, U-Vend America, Inc., U-Vend Canada, Inc. U-Vend USA LLC. All intercompany balances and transactions have been eliminated in consolidation.

  

Use of Estimates

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and be based on events different from those assumptions. Future events and their effects cannot be predicted with certainty; estimating, therefore, requires the exercise of judgment. Thus, accounting estimates change as new events occur, as more experience is acquired, or as additional information is obtained.

 

Property and Equipment

 

Property and equipment are stated at cost less depreciation. Depreciation is provided using the straight-line method over the estimated useful life of the assets. Equipment has estimated useful lives between three and seven years. Expenditures for repairs and maintenance are charged to expense as incurred.

 

Impairment of Long-lived Assets

 

Long-lived assets, such as property and equipment and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount to the estimated future undiscounted cash flows expected to be generated by the asset group. If it is determined that an asset group is not recoverable, an impairment charge is recognized for the amount by which the carrying amount of the asset group exceeds its fair value.

 

Earnings Per Share

 

The Company presents basic and diluted earnings per share in accordance with ASC 260, “Earnings per Share.” Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period. Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued. In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive.

 

As of March 31, 2021 and December 31, 2020, there were approximately 167 million and 166 million shares, respectively, potentially issuable under convertible debt agreements, options, and warrants that could dilute basic earnings per share in the future that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive to the Company’s losses during the periods presented.

  

		Three Months Ended
		March 31,
		2021				2020
Numerator:
Net income (loss)			1,614,076				(218,196	)
(Gain) loss on change in fair value of derivatives			(1,852,133	)			-
Interest on convertible debt			195,889				-
Net income (loss) - diluted			(42,168	)			(218,196	)
Denominator:
Weighted average common shares outstanding			100,299,993				37,717,755
Effect of dilutive shares			167,215,045				-
Diluted			267,515,038				37,717,755
Net income (loss) per common share:
Basic		$	0.02			$	(0.01	)
Diluted		$	(0.00	)		$	(0.01	)

 

For the three months ended March 31, 2020, the convertible instruments are anti-dilutive and therefore, have been excluded from earnings (loss) per share.

 

 

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Certain warrants issued by the Company contain terms that result in the warrants being classified as derivative liabilities for accounting purposes. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair market value and then is revalued at each reporting date, with changes in fair value reported in the consolidated statement of operations. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash and equivalents, accounts receivable, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities. ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows:

 

●

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis

 

●

Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes those derivative instruments that the Company values using observable market data. Substantially all of these inputs are observable in the marketplace throughout the term of the derivative instruments, can be derived from observable data, or supported by observable levels at which transactions are executed in the marketplace.

 

●

Level 3: Measured based on prices or valuation models that require inputs that are both significant to the fair value measurement and less observable from objective sources (i.e. supported by little or no market activity). Level 3 instruments include derivative warrant instruments. The Company does not have sufficient corroborating evidence to support classifying these assets and liabilities as Level 1 or Level 2.

 

Certain of the Company’s debt and equity instruments include embedded derivatives that require bifurcation from the host contract under the provisions of ASC 815-40, “Derivatives and Hedging.”

 

The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2021 and December 31, 2020:

 

						Fair Value Measurement at
		Carrying				March 31, 2021
		Value				Level 1				Level 2				Level 3
Derivative liabilities, debt and equity instruments		$	1,231,122				—				—			$	1,231,122

 

						Fair Value Measurement at
		Carrying				December 31, 2020
		Value				Level 1				Level 2				Level 3
Derivative liabilities, debt and equity instruments		$	3,083,255				—				—			$	3,083,255

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation,” that requires all stock-based awards granted to employees, directors, and non-employees to be measured at grant date fair value of the equity instrument issued, and recognized as expense. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award, which is generally equivalent to the vesting period. The fair value of each stock option granted is estimated using the Black-Scholes option pricing model. The measurement date for the non-forfeitable awards to nonemployees that vest immediately is the date the award is issued.

 

Gain on Liabilities Settlement

 

During the three months ended March 31, 2021 creditors forgave aggregate amount of $ $15,252 associated with accrued expenses. In addition, the Company recorded a gain on capital lease settlement of $16,074 as detailed in Note 6, resulting in total gain on settlement of liabilities of $31,326.

 

Revenue Recognition

 

We recognize revenue under Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), the core principle of which is that an entity should recognize revenue to depict the transfer of control for promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In applying the revenue recognition principles, an entity is required to identify the contract(s) with a customer, identify the performance obligations, determine the transaction price, allocate the transaction price to the performance obligations and recognize revenue as the performance obligations are satisfied (i.e., either over time or at a point in time). ASC 606 further requires that companies disclose sufficient information to enable readers of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. 

  

 

Recent Accounting Pronouncements

 

On August 5, 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This ASU is effective for public business entities, excluding smaller reporting companies, for fiscal years beginning after December 15, 2021, and for all other entities for fiscal years beginning after December 15, 2023. Early adoption is permitted for all entities no earlier than for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effects this ASU will have on its financial statements.

 

The Company has examined all recent accounting pronouncements and determined that they will not have a material impact on its financial position, results of operations, or cash flows.

 

Note 3 – Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis. The Company reported net gain of $1,614,075 for the three months ended March 31, 2021 and has incurred accumulated losses totaling $16,516,380 through March 31, 2021. In addition, the Company has incurred negative cash flows from operating activities since its inception. The Company has relied on the proceeds from loans and private sales of its stock, in addition to its revenues, to finance its operations. These factors, among others, indicate that the Company may be unable to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

With the onset of the Covid 19 pandemic, the reduction of foot traffic and closure of retail locations, management has been proactively looking at new business models and opportunities to stabilize revenues and continue to grow the Company. Until the Company can generate significant cash from operations, its ability to continue as a going concern is dependent upon obtaining additional financing. The Company hopes to raise additional financing, potentially through the sale of debt or equity instruments, or a combination, to fund its operations for the next 12 months and allow the Company to continue the development of its business plans and satisfy its obligations on a timely basis. Should additional financing not be available, the Company will have to negotiate with its lenders to extend the repayment dates of its indebtedness. There can be no assurance that the Company will be able to successfully restructure its debt obligations in the event it fails to obtain additional financing. These conditions have raised substantial doubt as to the Company’s ability to continue as a going concern for one year from the issuance of the financial statements, which has not been alleviated.

 

Note 4 – Property and Equipment

 

Property and equipment consist of the following as of March 31, 2021 and December 31, 2020:

 

		March 31, 2021				December 31, 20120
Freezers and other equipment		$	17,500			$	61,600
Delivery vans			-				-
Less: accumulated depreciation			-				-
Total		$	17,500			$	61,600

 

During the three months ended March 31, 2020, the Company received proceeds of $18,000 from the sale of freezers and other equipment, resulting in a loss on sale of assets of $ $12,074. During the three months ended March 31, 2021, the Company remitted leased assets with a carrying value of $44,100 back to the lessors in settlement of the underlying lease liability (Note 6).

 

Note 5 – Debt

 

Senior Convertible Notes

 

During the year ended December 31, 2018, a Senior Convertible Note in the aggregate principal amount of $310,000 and a maturity date of December 31, 2018 payable to Cobrador Multi-Strategy Partners, LP (“Cobrador 1”), was extended until December 31, 2019. The Company also extended the expiration dates of Series A Warrants issued in connection with Cobrador 1 by one year. The fair value of the Series A Warrants did not materially change due to the extension. During the year ended December 31, 2020, principal and accrued interest in the amount of $55,788 were converted into 14,760,086 shares of common stock. The carrying value as of December 31, 2020 was $268,900. During the three months ended March 31, 2021, total principal and accrued interest in the amount of $206,715 were converted into 54,398,684 shares of common stock resulting in carrying value of $155,000 as of March 31, 2021.

 

On June 30, 2016, the Company issued a Senior Convertible Note in the face amount of $108,804 to Cobrador (“Cobrador 2”) in settlement of previously accrued interest, additional interest, fees and penalties. The additional interest, fees and penalties was $72,734 and this amount was charged to operations as debt discount amortization during the year ended December 31, 2016. The Senior Convertible Note was extended during the year ended December 31, 2018 and was due on December 31, 2019. It is convertible into shares of common stock at a conversion price $0.05 per share and bears interest at 7% per annum. The Company determined that Cobrador 2 had a beneficial conversion feature based on the difference between the conversion price and the market price on the date of issuance and allocated $87,043 as debt discount representing the beneficial conversion feature which was fully amortized at December 31, 2017. The carrying value as of March 31, 2021 and December 31, 2020, was $108,804.

 

During December 2017, the Company issued a Senior Convertible Note in the amount of $25,000 to Cobrador. The note bears interest at 7%, was due in December 2019, and is convertible into common shares at a conversion price of $0.05 per share. In addition, in conjunction with this note, the Company issued 500,000 warrants to purchase common shares at $0.05 with a contractual term of 5 years. The estimated value of the warrants was determined to be $1,421 and was recorded as interest expense during 2017 and a warrant liability due to the down round provision in the note agreement. The carrying value as of March 31, 2021 and December 31, 2020, was $25,000.

 

As of the date of release of these financial statements, all senior convertible notes were in default. 

 

 

Promissory Notes Payable

 

During 2014, the Company issued an unsecured promissory note to a former employee of U-Vend Canada. The original amount of this note was $10,512 has a term of 3 years and accrues interest at 17% per annum. The total principal outstanding on this promissory note as of March 31, 2021 and December 31, 2020, was $6,235.

 

Starting of 2015, the Company entered into a series of promissory notes from the same lender. All of the notes bear interest at a rate of 19% per annum and are payable together with interest over a period of six (6) months from the date of borrowing. As of December 31, 2015, note balance was $11,083. In 2016, the Company borrowed $76,500 and repaid $63,497. The balance outstanding on these notes was $24,116 at December 31, 2016. In 2017, the Company borrowed $36,400 and repaid $44,449. The balance outstanding on these notes was $16,067 at December 31, 2017. In 2018, the Company borrowed $143,908 and repaid $125,931. The balance outstanding on these notes was $34,044 at December 31, 2018. During the year ended December 31, 2019, the Company borrowed additional $38,325 and recorded additional original discount in the amount of $3,325 associated with the new borrowing. During the year ended December 31, 2019, the Company repaid $46,584 in principal and fully amortized $3,325 of debt discount. As of March 31, 2021 and December 31, 2020, the balance outstanding on these notes was $25,784.

 

During the year ended December 31, 2016, the Company issued two unsecured promissory notes and borrowed an aggregate amount of $80,000. The promissory notes bear interest at 10% per annum, with a provision for an increase in the interest rate upon an event of default as defined therein and were due at various due dates in May and September 2017. The due dates of both notes were extended to December 31, 2019. As of March 31, 2021 and December 31, 2020, the balance outstanding on these notes was $80,000.

 

In December 2017, the Company issued promissory notes in the aggregate principal balance of $28,000 to Cobrador. The notes accrue interest at 7% and have a two-year term. As of March 31, 2021 and December 31, 2020, the balance outstanding on these notes was $28,000.

  

On April 13, 2018, the Company issued a promissory note in the principal amount of $115,000. This note bears interest at the rate of 7% per annum, due on December 31, 2019. In 2019, the Company borrowed an additional $25,000 and repaid $60,000. The balance outstanding on this note as of March 31, 2021 and December 31, 2020, was $80,000.

  

On November 19, 2018, the Company issued a promissory note in the principal amount of $124,000 with net proceeds of $112,840. This note matures in 64 weeks. The Company recorded $11,160 to debt discount. During the year ended December 31, 2018, the Company repaid $9,784 in principal and amortized $872 of debt discount resulting in an unamortized debt discount of $10,288 and carrying value of $103,928 at December 31, 2018. During the year ended December 31, 2019, the Company repaid $48,154 in principal and amortized $9,744 of debt discount resulting in an unamortized debt discount of $544 and carrying value of $65,518 at December 31, 2019. During the year ended December 31, 2020, the Company repaid $15,000 in principal and fully amortized $544 of debt discount. As of December 31, 2020, the balance outstanding on this note was $51,062. During the three months ended March 31, 2021, the Company repaid $15,000 in principal resulting in carrying value of $36,062 as of March 31, 2021.

  

During the year ended December 31, 2019, the Company issued two promissory notes in the aggregate principal amount of $135,000, bearing interest of 7% and mature on August 31, 2019. As of March 31, 2021 and December 31, 2020, the balance outstanding on these notes was $135,000.

 

As of the date of release of these financial statements, promissory notes were in default.

 

On March 5, 2019, the Company issued a non-equity linked promissory note for $100,000 to an investor with an annual 10% rate of interest and a one (1) year maturity. This investor also received a warrant for 500,000 shares at a strike price of $0.07 per share with a five (5) year maturity. The fair value of warrant was not material. As of December 31, 2019, the outstanding balance was $100,000. On December 23, 2020, total principal and accrued interest in the amount of $118,250 were converted into a new promissory note in the principal amount of $118,250 with an annual 10% rate of interest and mature on January 15, 2022. As of March 31, 2021 and December 31, 2020, the outstanding balance was $118,250.

 

Convertible Notes Payable

 

2014 Stock Purchase Agreement

 

In 2014 and 2015 the Company entered into the 2014 Securities Purchase Agreement (the “2014 SPA”) pursuant to which it issued eight (8) convertible notes in the aggregate face amount of $146,000 due at various dates between August 2015 and March 2016. The principal on these notes is due at the holder’s option in cash or common shares at a conversion rate of $0.30 per share. In connection with these borrowings the Company granted a total of 360,002 warrants with an exercise price of $0.35 per share and a 5 year contractual term. The warrants issued have a down round provision and as a result are classified as a liability in the accompanying consolidated balance sheets. Pursuant to the down round provision, the exercise price of the warrants was reduced to $0.22 at December 31, 2016. During 2017 the Company repaid one of the notes in the amount of $50,000. On May 1, 2018, the Company granted 1,000,000 warrants with an exercise price of $0.15 per share and a 5 year contractual term, valued at $2,841, which was recorded as debt discount. As of March 31, 2021 and December 31, 2020, outstanding balance of these notes was $121,000. As of the date of release of these financial statements, these notes were in default.

 

 

The Company and Cobrador held three of the convertible notes in the aggregate face amount of $45,000 and agreed to extend the repayment date to November 17, 2020. The Company agreed to a revised conversion price of $0.05 per share and a revised warrant exercise price of $0.07 per share. The change in the value of warrants was not material and was charged to operations during the year ended December 31, 2017. As of March 31, 2021 and December 31, 2020, outstanding balance of these notes was $45,000.

 

2015 Stock Purchase Agreement

 

During the year ended December 31, 2015, the Company issued eleven subordinated convertible notes bearing interest at 9.5% per annum with an aggregate principal balance of $441,000 pursuant to the 2015 Stock Purchase Agreement (the “2015 SPA”). The notes were due in December 2017 and are payable at the noteholder’s option in cash or common shares at a conversion rate of $0.30 per share. The conversion rate was later revised to $0.05 due to down round provisions contained in the 2015 SPA, and the due date was extended to November 17, 2020. In connection with these borrowings, the Company issued a warrant to purchase 735,002 shares of the Company’s common stock at an exercise price of $0.40 per share and a 5 year contractual term. The exercise price was later revised to $0.22 per share pursuant to the down round provisions in the 2015 SPA. The Company allocated $8,113 of proceeds received to debt discount based on the computed fair value of the convertible notes and warrants issued. During the year ended December 31, 2016, the noteholder converted one note in the face amount of $35,000 into 700,000 shares of common stock. As of March 31, 2021 and December 31, 2020, the 2015 SPA had a balance of $406,000. The debt discount was fully amortized as of December 31, 2016.

 

2016 Stock Purchase Agreement

 

On June 30, 2016, the Company entered into the 2016 Stock Purchase Agreement (the “2016 SPA”) pursuant to which it issued five convertible notes in the aggregate principal amount of $761,597. The 2016 SPA notes were due in November 2020 and bear interest at 9.5% per annum. The notes are convertible into shares of common stock at a conversion price of $0.17 per share. With these notes, the Company satisfied its obligations for: previously issued promissory notes of $549,000, accrued interest of $38,615, lease principal installments of $47,466, previously accrued registration rights penalties of $22,156, due to a former officer of $81,250, and additional interest, expenses, fine and penalties of $23,110. The Company charged additional interest, expenses, fines and penalties $23,110 to operations as amortization of debt discount and deferred financing costs during the year ended December 31, 2016.

 

In connection with the 2016 SPA, the Company granted a total of 2,239,900 warrants with an exercise price of $0.30 per share which was later revised to $0.05 per share due to down round provisions, with a 5 year contractual life. The Company allocated $19,242 to debt discount based on the computed fair value of the convertible notes and warrants issued and classified the debt discount is as a warrant liability due to the down round provision in the warrants.

 

On July 11, 2019, $85,000 in principal were converted into 1,700,000 shares of common stock.  

 

As of March 31, 2021 and December 31, 2020, the 2016 SPA had a carrying value of $676,597. As of the date of release of these financial statements, these notes were in default.

 

Other 2016 Financings

 

During the year ended December 31, 2016, the Company issued four convertible notes (the “Cobrador 2016 Notes”) in the aggregate principal amount of $115,000. The Cobrador 2016 Notes have a 2 year term, bear interest at 9.5% per annum, and are convertible into shares of common stock at a conversion price of $0.17 per share. The conversion price was subsequently revised to $0.05 per the down round provisions and the maturity date was extended to September 26, 2021. In connection with the Cobrador 2016 Notes, the Company granted a total of 338,235 warrants with an exercise price of $0.30 per share which was subsequently revised to $0.05 per share due to down round provisions with a 5 year contractual term. The Company allocated $1,994 to debt discount based on the computed fair value of the convertible notes and warrants issued and classified the debt discount as a warrant liability due to the down round provision in the warrants. During the year ended December 31, 2019, $20,000 was converted into 400,000 shares. As of March 31, 2021 and December 31, 2020, the Cobrador 2016 Notes had a carrying value of $95,000.

 

During the fourth quarter of 2016, the Company issued three additional convertible notes in the aggregate principal amount of $250,000. The notes have a 2 year term, bear interest at 9.5% per annum and are convertible into shares of common stock at a conversion price of $0.05 per share. In connection with these borrowings, the Company granted warrants to purchase 5,000,000 shares of common stock with an exercise price of $0.07 per share. The Company allocated $27,585 to debt discount based on the computed fair value of the convertible notes and warrants issued, and the debt discount is classified as a warrant liability due to the down round provision in the warrants. As of March 31, 2021 and December 31, 2020, the carrying value of the notes was $250,000. As of the date of release of these financial statements, these notes were in default.

 

 

2017 Financings

 

During the year ended December 31, 2017, the Company entered into 19 separate convertible notes agreements (the “2017 Convertible Notes)” in the aggregate principal amount of $923,882. The 2017 Convertible Notes each have a 2 year term, bear interest at 9.5%, and are convertible into shares of common stock at a conversion price of $0.05 per share. In connection with the 2017 Convertible Notes, the Company issued a total of 16,537,926 warrants with an exercise price of $0.07 per share with a 5 year term. The Company allocated $59,403 to a debt discount based on the computed fair value of the convertible notes and warrants issued and classified the debt discount as a warrant liability due to the down round provision in the warrants. During the year ended December 31, 2018, the Company amortized $31,940 of debt discount resulting in unamortized debt discount of $13,278 and carrying value of $910,608 at December 31, 2018. During the year ended December 31, 2019, the Company fully amortized remaining $13,278 of debt discount. As of March 31, 2021 and December 31, 2020, the carrying value of the notes was $924,282. As of the date of release of these financial statements, these notes were in default.

 

2018 Financings

 

During the year ended December 31, 2018, the Company entered into seventeen separate convertible notes agreements (the “2018 Convertible Notes)” in the aggregate principal amount of $537,500. The 2018 Convertible Notes each have a 2 year term, bear interest at 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.05 per share. In connection with the 2018 Convertible Notes, the Company issued a total of 10,750,000 warrants with an exercise price of $0.07 per share with a 5 year term. The Company allocated $33,384 to a debt discount based on the computed fair value of the convertible notes and warrants issued and classified the debt discount as a warrant liability due to the down round provision in the warrants. During the year ended December 31, 2018, the Company amortized $12,803 of debt discount resulting in an unamortized debt discount of $20,581 and carrying value of $516,919 at December 31, 2018. During the year ended December 31, 2019, the Company amortized $16,692 of debt discount resulting in an unamortized debt discount of $3,889 and carrying value of $533,611 as of December 31, 2019. During the year ended December 31, 2020, the Company fully amortized $3,889 of debt discount resulting in carrying value of $537,500 as of March 31, 2021 and December 31, 2020. As of the date of release of these financial statements, convertible notes were in default.

 

On November 20, 2018, two officers converted $436,500 accrued compensation into two convertible note agreements in the principal amount of $436,500 in exchange. The notes have a 2 year term, bear interest at 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.05 per share. As of March 31, 2021 and December 31, 2020, the carrying value of the notes was $436,500. As of the date of release of these financial statements, convertible notes were in default.

 

During the year ended December 31, 2018, the Company entered into three convertible notes agreements in the aggregate principal amount of $240,500 with a net proceed of $214,000. These notes had a 1-year term, and bear interest at 8%-12%. The notes are convertible into common stock at 60% to 61% multiplied by the lowest one to two trading price(s) during fifteen to twenty-five trading day period prior to the Conversion Date. The embedded conversion features were valued at $59,027, which were recorded as debt discount. In addition, the Company also recorded $26,500 as original debt discount. These notes were in default due to failure to comply with the reporting requirements of the Exchange Act, as the result, the Company recorded additional $120,250 penalty in principal as of December 31, 2018. During the year ended December 31, 2018, the Company amortized $21,382 of debt discount resulting in unamortized debt discount of $64,145 and carrying value of $296,605 at December 31, 2018. During the year ended December 31, 2019, the Company repaid $64,300 in principal and amortized $21,381 of debt discount, recorded $42,764 in accretion of debt discount, resulting in unamortized debt discount of $0 and carrying value of $296,450 at December 31, 2019. During the year ended December 31, 2020, total principal and accrued interest in the amount of $37,712 were converted into 9,924,132 shares of common stock. As of March 31, 2021 and December 31, 2020, the carrying value of the notes was $281,250

  

2019 Financings

 

On March 18, 2019, the Company issued a convertible promissory note for $85,250 with net proceed of $75,000 to an investor with an 8.0% rate of interest and a one (1) year maturity. The Company has the option to pre-pay the note (principal and accrued interest) in cash within the 1st 90 days from issuance at a 25% premium, and 40% premium 91-180 days from the issuance date. Subsequent to 181 days, the Company shall have no right of prepayment and the holder may convert at a 40% discount to the prevailing market price. The note matured on December 11, 2019. The note is convertible into shares of common stock at the lesser of 1) lowest trading price of twenty-five days prior to March 18, 2019 or 2) 60% of lowest trading price of twenty-five days prior to the Conversion Day. The embedded conversion features were valued at $0 due to default. In addition, the Company also recorded $10,250 as original debt discount. These notes were in default due to failure to comply with the reporting requirements of the Exchange Act, as the result, the Company recorded additional $42,625 penalty in principal as of December 31, 2019. During the year ended December 31, 2019, the Company fully amortized $23,384 of debt discount. During the year ended December 31, 2020, accrued interest in the amount of $24,508 was converted into 13,426,091 shares of common stock. As of March 31, 2021 and December 31, 2020, the carrying value of the note was $127,875. As of the date of release of these financial statements, convertible note was in default.

 

On March 14, 2019, the Company converted accounts payable of approximately $105,000 payables into a convertible note agreement in the principal amount of $60,000, remaining balance of the amount owed was released and recorded as a settlement of liability. The note has a 2 year term, bears interest at 9.5% if paid in cash, 15% if paid in common stock, and is convertible into shares of common stock at a conversion price of $0.05 per share. The outstanding principal balance was $60,000 as of March 31, 2021 and December 31, 2020. As of the date of release of these financial statements, convertible note was in default.

 

On April 1, 2019, The Company converted an aggregate amount of principal and accrued interest of Perkins promissory note in the amount of $321,824 and accounts payable of $10,000 into two convertible notes. Both Notes have a 2 year term, bear interest at 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.05 per share. The outstanding principal balance was $331,824 as of March 31, 2021 and December 31, 2020.

 

 

On April 15, 2019, The Company converted an accrued payable of $108,572, which was used to purchase vending machine, into a convertible note. The note has a 2 year term, bear interest at 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.07 per share. The outstanding principal balance was $108,572 as of March 31, 2021 and December 31, 2020.

 

On May 30, 2019, the Company issued a series of convertible notes under a $250,000 revolving Senior Secured credit facility to an investor, for working capital purposes. The notes carry an interest rate of 9.5% and a two-year term. The notes are convertible into common stock at $0.07 per share and are redeemable after one-year at the company’s option. The notes also contain a 4.99% limitation of ownership on conversion. The investor had consented to higher draws on the facility in excess of the limit per the initial agreement. On April 15, 2020, the Company issued a convertible note in the amount of $206,231. The note has a 2 year term, bears interest of 9.5% if paid in cash, 15% if paid in common stock, and is convertible into shares of common stock at a conversion price of $0.05 per share. On December 24, 2020, the Company issued a convertible promissory note in the amount of $147,000. The note has a 2 year term, bears interest of 9.5% if paid in cash, 15% if paid in common stock, and is convertible into shares of common stock at a conversion price of $0.03 per share and is redeemable at the principal amount plus accrued unpaid interest after one year, at the Company’s option. As of March 31, 2021 and December 31, 2020, $603,231 was drawn under these agreements.

 

During the year ended December 31, 2019, the Company entered into several convertible notes agreements in the amount of $68,000. The Notes have a 2 year term, bear interest at 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.07 per share. The outstanding principal balance was of $68,000 as of March 31, 2021 and December 31, 2020.

 

During the year ended December 31, 2019, the Company entered into a convertible notes agreement in the amount of $50,000. The Note has a 6 month term, bears interest at 9.5% if paid in cash, 15% if paid in common stock, and is convertible into shares of common stock at a conversion price of $0.01 per share. In connection with the Note, the Company issued 10,000,000 warrants with an exercise price of $0.02 per share with a 5 year term. The outstanding balance was of $50,000 as of March 31, 2021 and December 31, 2020.

 

2020 Financings

 

During the year ended December 31, 2020, the Company entered into several convertible note agreements in the amount of $73,118. The notes have a 2 year term, bear interest of 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.05 per share. The outstanding principal balance was $73,118 as of March 31, 2021 and December 31, 2020.

 

2021 Financings

 

During the three months ended March 31, 2021, the Company entered into several convertible note agreements in the amount of $125,000. The notes have a 2 year term, bear interest of 9.5% if paid in cash, 15% if paid in common stock, and are convertible into shares of common stock at a conversion price of $0.05 per share. The outstanding principal balance was $125,000 as of March 31, 2021.

 

During the three months ended March 31, 2021, the Company issued a convertible note for deferred compensation in the principal amount of $94,600, which is comprised of $47,500 of deferred compensation already included in an existing convertible note at December 31, 2020, and $47,100 of current period accrual conversions. The note bears interest at the rate of 9.5% per annum and is due and payable in two years. The note is convertible into shares of the Company’s common stock at $0.05 per share and is redeemable at the principal amount plus accrued unpaid interest after one year, at the Company’s option. The outstanding principal balance was $94,600 as of March 31, 2021.

 

Scheduled maturities of debt remaining as of March 31, 2021 for each respective fiscal year end are as follows:

 

2021		$	5,449,285
2022			646,699
2023			125,000
			6,220,984
Less: unamortized debt discount			-
		$	6,220,984

 

The following table reconciles, for the three months ended March 31, 2021 and 2020, the beginning and ending balances for financial instruments related to the embedded conversion features that are recognized at fair value in the consolidated financial statements.

 

		March 31, 2021				March 31, 2020
Balance of embedded derivative at the beginning of the period		$	3,083,255			$	13,553
Change in fair value of conversion features			(1,852,133	)			394
Balance of embedded derivatives at the end of the period		$	1,231,122			$	13,947

 

 

Note 6 – Capital Lease Obligations

 

The Company acquired capital assets under capital lease obligations. Pursuant to the agreement with the lessor, the Company makes quarterly lease payments and will make a guaranteed residual payment at the end of the lease as summarized below. At the end of the lease, the Company will own the equipment.

 

During the year ended December 31, 2018 the Company entered into various minimal capital lease agreements. The leases expire at various points through the year ended December 31, 2023. During the three months ended March 31, 2021, the Company settled lease liability amounts totaling $117,174 by paying the lessors $57,000 and returning the leased property and equipment with a carrying value of $44,100, resulting in a gain on settlement of liability of $16,074.

  

The following schedule provides minimum future rental payments required as of March 31, 2021, under the current portion of capital leases.

 

2021		$	52,480
2022			10,424
2023			5,212
Total minimum lease payments			68,116
Less: Amount represented interest			(7,675	)
Present value of minimum lease payments and guaranteed residual value		$	60,441

 

Note 7 – Capital Stock

 

Preferred Stock

 

The Company has authorization for “blank check” preferred stock, which could be issued with voting, liquidation, dividend and other rights superior to common stock. As of March 31, 2021 and December 31, 2020, there are 10,000,000 shares of preferred stock authorized, and no shares issued or outstanding.

 

Common Stock

 

The Company has authorized 600,000,000 shares of common stock.

   

During the three months ended March 31, 2021, the Company issued 54,398,674 shares of its common stock, in conversion of $206,715 of convertible notes and accrued interest.

 

Note 8 – Stock Options and Warrants

 

Warrants

 

At March 31, 2021, the Company had the following warrant securities outstanding:

 

		Warrants				Exercise Price				Expiration
2016 Warrants - 2016 SPA convertible debt			2,239,990			$	0.05			June 2021
2016 Warrants for services			850,000			$	0.05			June 2021
2016 Warrants - Convertible notes			338,236			$	0.05			August - September 2021
2016 Warrants for services			200,000			$	0.07			October 2020
2016 Warrants issued with Convertible Notes			5,000,000			$	0.07			November -December 2021
2017 Warrants – 2017 financing			15,109,354			$	0.07			December 2022
2018 Warrants – 2019 financing			9,941,905			$	0.07			January - November 2023
2018 Warrants for services			2,300,000			$	0.07			October - December 2023
2019 Warrants – 2020 financing			10,500,000			$	0.07			March 2024
2019 Warrants for services			3,500,000			$	0.07			March 2024
2020 Warrants for services			3,000,000			$	0.05			February 2025
Total			52,979,485

 

During the three months ended March 31, 2020, the Company issued warrants exercisable into 3,000,000 shares of common stock to its officer. The fair value of warrants was determined to be $12,594, and was estimated using the Black-Scholes-Merton option-pricing model with the following assumptions: expected volatility of 339%, risk-free interest rate 1.35%, expected dividend yield of 0%. During the three months ended March 31, 2021, the Company recorded $1,574 in warrant expense related to vesting of these warrants.

 

A summary of all warrant activity as of and for the three months ended March 31, 2021 is as follows:

 

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term
Balance outstanding at December 31, 2020			52,979,485			$	0.06				2.34
Granted			-				-				-
Exercised			-				-				-
Forfeited			-				-				-
Cancelled			-				-				-
Expired			-				-				-
Balance outstanding at March 31, 2021			52,979,485			$	0.06				2.09
Exercisable at March 31, 2021			52,979,485			$	0.06				2.09

 

 

Equity Incentive Plan

 

On July 22, 2011, the Board of Directors of the Company approved the Company’s 2011 Equity Incentive Plan (the “Plan”) and on July 26, 2011, stockholders holding a majority of shares of the Company approved, by written consent, the Plan and the issuance under the Plan of 5,000,000 shares. On November 16, 2017, the Board of Directors approved an increase of 10,000,000 shares to be made available for issuance under the Plan. Accordingly, the total number of shares of common stock available for issuance under the Plan is 15,000,000 shares. Awards may be granted to employees, officers, directors, consultants, agents, advisors and independent contractors of the Company and its related companies. Such options may be designated at the time of grant as either incentive stock options or nonqualified stock options. Stock-based compensation includes expense charges related to all stock-based awards. Such awards include options, warrants and stock grants. Generally, the Company issues stock options that vest over three years and expire in 5 to 10 years.

 

A summary of all stock option activity as of and for the three months ended March 31, 2021 is as follows:

 

		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term
Balance outstanding at December 31, 2020			2,500			$	60				0.5
Granted			-				-				-
Exercised			-				-				-
Cancelled or expired			-				-				-
Balance outstanding at March 31, 2021			2,500			$	60				0.3
Exercisable at March 31, 2021			2,500			$	60				.3

 

Note 10 – Subsequent Events

 

The Company has evaluated events occurring subsequent to March 31, 2021 through the date these financial statements were issued and determined the following significant events require disclosure:

 

Subsequent to March 31, 2021, the Company issued multiple convertible promissory notes in the aggregate principal amount of $390,000 to unaffiliated investors. The notes bear interest at the rate of 9.5% per annum and are due and payable in two years. The notes are convertible into shares of the Company’s common stock at $0.05 per share and are redeemable at the principal amount plus accrued unpaid interest after one year, at the Company’s option.

 

Subsequent to March 31, 2021, the Company issued 96,377,291 of its common stock in conversion of $361,874 of convertible notes.

 

Subsequent to March 31, 2021, the Company hired Patrick Avery as the Company’s Chief Operating Officer with a salary of $84,000.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “1995 Reform Act”). BoxScore Brands, Inc. desires to avail itself of certain “safe harbor” provisions of the 1995 Reform Act and is therefore including this special note to enable us to do so. Except for the historical information contained herein, this report contains forward-looking statements (identified by the words “estimate,” “project,” “anticipate,” “plan,” “expect,” “intend,” “believe,” “hope,” “strategy” and similar expressions), which are based on our current expectations and speak only as of the date made. These forward-looking statements are subject to various risks, uncertainties and factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements, including, without limitation, those discussed under Part I, Item 1A “Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2020, and those described herein that could cause actual results to differ materially from the results anticipated in the forward-looking statements, and the following:

  

●

Our limited operating history with our business model;

 

●

The low cash balance and limited financing currently available to us. We may in the near future have a number of obligations that we will be unable to meet without generating additional income or raising additional capital;

 

●

Further cost reductions or curtailment in future operations due to our low cash balance and negative cash flow;

 

●

Our ability to effect a financing transaction to fund our operations which could adversely affect the value of our stock;

 

●

Our limited cash resources may not be sufficient to fund continuing losses from operations;

 

●

The failure of our products and services to achieve market acceptance; and

 

●

The inability to compete in our market, especially against established industry competitors with greater market presence and financial resources.

 

The following discussion and analysis provides information that our management believes is relevant to an assessment and understanding of our results of operations and financial condition, and should be read in conjunction with the consolidated financial statements and footnotes that appear elsewhere in this report.

 

Overview

 

BoxScore Brands, Inc. (formerly U-Vend Inc.) (the “Company”) formerly developed, marketed and distributed various self-serve electronic kiosks and mall/airport co-branded islands throughout North America. Due to the nationwide shutdown related to the COVID-19 pandemic, the Company spent a portion of 2020 restructuring and retiring certain corporate debt and obligations. The Company focused on implementing a new operational direction.  After a thorough evaluation process, the Company found that there is a substantial long-term demand for specific commodities relating to battery and new energy technologies. This presents a timely and unique opportunity based on rising demand characteristics.  By capitalizing on market trends and current sustainable energy government mandates and ESG initiatives, we will focus on bringing a vertically-integrated solution to market.

 

Results of Operations

 

Three months Ended March 31, 2021 Compared to Three months Ended March 31, 2020

 

Revenue

 

For the three months ended March 31, 2021 and 2020, the Company had no revenue.

 

General and Administrative Expenses

 

General and administrative expenses for the three months ended March 31, 2021 were $73,495, an increase of $21,913 or 42%, compared to $51,582 for the three months ended March 31, 2021. The increase in general and administrative expenses was mainly due to increase in wages and professional fees.

   

 

Gain on Fair Value of Derivative Liabilities

 

During the three months ended March 31, 2021, the Company recorded a gain on the change in fair value of derivative liabilities of $1,852,133, as compared to a loss on the change in fair value of derivative liabilities $394 during the three months ended March 31, 2020.

 

Amortization of Debt Discount and Deferred Financing Costs

 

Amortization of debt discount and deferred financing costs for the three months ended March 31, 2021 were $0, compared to $2,657 for the three months ended March 31, 2020.

 

Interest Expense

 

Interest expense for the three months ended March 31, 2021 was $195,889, as compared to $151,489 during the three months ended March 31, 2020.

 

Net Loss

 

As a result of the foregoing, the net income for the three months ended March 31, 2021 was $1,614,075 as compared to a net loss of $218,196 incurred during the three months ended March 31, 2020.

  

Liquidity and Capital Resources

 

The accompanying consolidated financial statements have been prepared on a going concern basis. The Company had net income of $1,614,075 during the three months ended March 31, 2021, has accumulated losses totaling $16,516,380, and has a working capital deficit of $8,197,708 as of March 31, 2021. These factors, among others, indicate that the Company may be unable to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

The Company will need to raise additional financing in order to fund its operations for the next 12 months, and to allow the Company to continue the development of its business plans and satisfy its obligations on a timely basis. Should additional financing not be available, the Company will have to negotiate with its lenders to extend the repayment dates of its indebtedness. There can be no assurance that the Company will be able to successfully restructure its debt obligations in the event it fails to obtain additional financing.

 

Operating Activities

 

During the three months ended March 31, 2021, the Company used $55,652 of cash in operating activities primarily as a result of the Company’s net income of $1,614,075, offset by share-based compensation of $1,574, change in fair market value of derivative liability of $1,852,133, gain on settlement of liabilities of $31,326, and net changes in operating assets and liabilities of $212,158.

 

During the three months ended March 31, 2020, the Company used $15,079 of cash in operating activities primarily as a result of the Company’s net loss of $218,196, offset by loss on change in fair value of derivative liabilities of $394, loss on sale of asset of $12,074, $2,657 in amortization and accretion of debt discount, and net changes in operating assets and liabilities of $187,992.

 

Investing Activities

 

During the three months ended March 31, 2021, the Company had no investing activities.

 

During the three months ended March 31, 2020, investing activities provided $18,000 in cash in proceeds from sale of property and equipment.

 

Financing Activities

 

During the three months ended March 31, 2021, financing activities provided $53,000, resulting from $125,000 in proceeds from convertible notes, $57,000 in repayments of capital lease obligations and $15,000 in repayments of promissory notes.

 

During the three months ended March 31, 2020, we used $2,921 in financing activities, resulting from $7,500 in proceeds from convertible notes and $10,421 in repayments of capital lease obligations.

 

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on its financial condition, financial statements, revenues or expenses.

 

Inflation

 

Although the Company’s operations are influenced by general economic conditions, it does not believe that inflation had a material effect on its results of operations during the last two years as it is generally able to pass the increase in material and labor costs to its customers or absorb them as it improves the efficiency of its operations.

 

Critical Accounting Policies

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make judgments, assumptions and estimates that affect the amounts reported in our consolidated financial statements and accompanying notes. The consolidated financial statements as of March 31, 2021 describe the significant accounting policies and methods used in the preparation of the consolidated financial statements. Actual results could differ from those estimates and be based on events different from those assumptions. Future events and their effects cannot be predicted with certainty; estimating therefore, requires the exercise of judgment. Thus, accounting estimates change as new events occur, as more experience is acquired or as additional information is obtained. The following critical accounting policies are impacted significantly by judgments, assumptions and estimates used in the preparation of our consolidated financial statements:

  

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash and equivalents, accounts receivable, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities. ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows:

 

●

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis

 

●

Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes those derivative instruments that the Company values using observable market data. Substantially all of these inputs are observable in the marketplace throughout the term of the derivative instruments, can be derived from observable data, or supported by observable levels at which transactions are executed in the marketplace.

 

●

Level 3: Measured based on prices or valuation models that require inputs that are both significant to the fair value measurement and less observable from objective sources (i.e. supported by little or no market activity). Level 3 instruments include derivative warrant instruments. The Company does not have sufficient corroborating evidence to support classifying these assets and liabilities as Level 1 or Level 2.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Certain warrants issued by the Company contain terms that result in the warrants being classified as derivative liabilities for accounting purposes. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair market value and then is revalued at each reporting date, with changes in fair value reported in the consolidated statement of operations. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures:

 

As of the end of the period covered by this Form 10-Q, management performed, with the participation of our principal executive officer and principal financial officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosures. Based on the evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2021, our disclosure controls and procedures were not effective.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. We identified the following material weakness as of March 31, 2021:

 

●

Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting;

 

●

Inability to apply GAAP consistently for routine transactions, and to unique transactions and contracts;

 

●

Inability to evaluate the adoption of new reporting standards; and

 

●

A lack of consistent management involvement during the financial statement preparation process.

 

To remediate our internal control weaknesses, management intends to implement the following measures, as finances allow:

 

	●	Adding sufficient accounting personnel or outside consultants to properly segregate duties and to effect a timely, accurate preparation of the financial statements;
	●	Adhering to internal procedures for timely submission of supporting documents to outside consultants;
	●	Developing and maintaining adequate written accounting policies and procedures, once we hire additional accounting personnel or outside consultants.

 

The additional hiring is contingent upon our efforts to obtain additional funding and the results of our operations. Management expects to secure funds in the coming fiscal year but provides no assurances that it will be able to do so.

 

(b) Changes in Internal Control over Financial Reporting:

 

There were no changes in the Company’s internal control over financial reporting during the three months ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. However, our management is currently seeking to improve our controls and procedures in an effort to remediate the deficiency described above.

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors.

 

In addition to the other information set forth in this report, you should carefully consider the factors discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on September 27, 2021. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

None.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits

 

31.1		Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and15d-14(a)
32.1		Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350
101.INS		XBRL Instance Document.
101.SCH		XBRL Taxonomy Extension Schema Document.
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	BOXSCORE BRANDS, INC.
September 27, 2021	By:	/s/ Andrew Boutsikakis
		Andrew Boutsikakis
		Chief Executive Officer, President and Chief Financial Officer

 

 

19

Exhibit 31.1

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

I, Andrew Boutsikakis, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of BoxScore Brands, Inc. for the quarterly period ended March 31, 2021.

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 27, 2021
/s/ Andrew Boutsikakis
Andrew Boutsikakis
President, Chief Executive Officer
(Principal Executive Officer) and Chief Financial Officer  (Principal Financial Officer)

 

 

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of BoxScore Brands, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Andrew Boutsikakis , Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date September 27, 2021
/s/ Andrew Boutsikakis
Andrew Boutsikakis
President, Chief Executive Officer
(Principal Executive Officer) and Chief Financial Officer  (Principal Financial Officer)

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Dow reports first quarter 2024 results
• Geopolitical Unrest Generates an Onslaught of DDoS Attacks, According to the Latest NETSCOUT Threat Intelligence Report
• Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million